Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: Diagnostic value, association with radiological damage and axial skeleton affection

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders

Volumn 3, Issue , 2010, Pages 33-42

  Mansour, Howaida E ^a   Metwaly, Khaled M ^b   Hassan, Iman A ^a   Elshamy, Hebat Allah A ^a   Elbeblawy, Moataz M S ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Saint Fatima Square Heliopolis   (Egypt)

Author keywords

Anti MCV; Anti mutated citrullinated vimentin; RA; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G; MUTATED CITRULLINATED VIMENTIN ANTIBODY; PROTEIN ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; BLOOD CELL COUNT; CERVICAL SPINE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; JOINT DESTRUCTION; JOINT RADIOGRAPHY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; PROSPECTIVE STUDY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 77955378365     PISSN: None     EISSN: 11795441     Source Type: Journal    
DOI: 10.4137/cmamd.s4827     Document Type: Article

References (31)

1. Bang H, Egerer K, Gauliard A, et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum. 2007;56(8):2503-11.
2. Van Gaalen F, Ioan-Facsinay A, Huizinga TW, Toes RE. The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J Immunol. 2005;175:5575-80.
3. Greiner A, Plischke H, Kellner H, Gruber R. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann NY Acad Sci. 2005;1050:295-303.
4. Levesque MC, Zhou Z, Moreland LW. Anti-cyclic citrullinated peptides testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value [editorial]. Arthritis Rheum. 2009;60:2211-5.
5. Vossenaar ER, Despres N, Lapointe E, et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther. 2004;6:R142-50.
6. Luime J, Colin E, Hazes J, Lubberts E. Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigations of patients with rheumatoid arthritis? A systemic review. Ann Rheum Dis. 2010;69:337-44.
7. Hirohashi N, Sakai T, Sairyo K, et al. Lumbar radiculopathy caused by extradural rheumatoid nodules. Case report. J Neurosurg Spine. 2007;7(3):352-6.
8. Narvaez JA, Narvaez J, Serrallonga M, et al. Cervical spine involvement in rheumatoid arthritis: Correlation between neurological manifestations and magnetic resonance imaging findings. Rheumatology (Oxford) 2008; 47(12):1814-9.
9. Sakai T, Sairyo K, Hamada D, et al. Radiological features of lumbar spinal lesions in patients with rheumatoid arthritis with special reference to the changes around intervertebral discs. The Spine Journal. 2008;(4):605-11.
10. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987, revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1987;31:315-24.
11. Mitchel L. Zoler: New Rheumatoid Arthritis Criteria Released by ACR/ EULAR Panel [Monday, October 26, 2009-Elsevier Global Medical News].
12. Van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998;41:1845-50.
13. Van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism (EULAR) response criteria for rheumatoid arthritis. Arthritis Rheum. 1996;(1):34-40.
14. Nardella FA, Dayer MJ, Roelke M, Krane MS, Mannik M. Self associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells. Rheumatology International. 1983;3:183-6.
15. Dias EM, Lukas C, Landewe R, Fatenejad S, van der Heijde D. Reliability and sensitivity to change of the simple erosion narrowing score compared with the Sharpvan der Heijde method for scoring radiographs in rheumatoid arthritis. Ann Rheum Dis. 2007;(67):375-9.
16. Hassey A, Gerrett D, Wilson A, David JR. A survey of validity and utility of electronic patient records in a general practice. BMJ. 2001;(322):1401-5.
17. Gross WL, Moosig F, Lamprecht P. Anticitrullinated protein/peptide antibodies in rheumatoid arthritis. Dtsch Arztebl Int. 2009;106(10):157-8.
18. Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43:155-63.
19. Jansen AL, van der Horst Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol. 2002;29:2074-6.
20. Saraux A, Berthelot JM, Devauchelle V, et al. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. J Rheumatol. 2003;30:2535-9.
21. Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study. Arthritis Rheum. 2004;50:709-15.
22. Vittecoq O, Incaurgarat B, Jouen-Beades F, et al. Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Clin Exp Immunol. 2004;135:173-80.
23. Niewold TB, Harrison MJ, Paget SA. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. QJM. 2007;100(4): 193-201.
24. Egerer K, Feist E, Burmester GR. The serological diagnosis of rheumatoid arthritis: Antibodies to citrullinated antigens. Dtsch Arztebl Int. 2009; 106(10):159-63.
25. Mathsson L, Mullazehi M, Wick MC, et al. Antibodies against citrullinated vimentin in rheumatoid arthritis: Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum. 2008;58:36-45.
26. Galvao V, Atta A, Sousa M, et al. Profile of antibodies in Jaccaud's arthropathy. Joint Bone Spine. 2009;76(4):356-60.
27. Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J Rheumatol. 2008;35:1002-8.
28. Keskin G, Inal A, Keskin D, et al. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis. Protein Pept Lett. 2008;15(3):314-7.
29. Syversen SW, Goll GL, van der Heijde D, et al. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: Results from a 10-year prospective study. Ann Rheum Dis. 2010;69:345-51.
30. Van der Heijde D, Dankert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of a simplification of the sharp/van der heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford). 1999;38:941-7.
31. Kauppi MJ, Neva MH, Laiho K, et al. Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs. J Rheumatol. 2009;36:273-8.